GlassScriptPhysician profile
Marissa Romano
NPI 1487133575
$1,067.19
in general payments reported to CMS, 2019-2025
19 companies · $66.67 in 2025
The $66.67 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $681 · 2023: $299 · 2024: $19.91 · 2025: $66.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $385.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $239.20 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $226.08 | 2022-2023 | Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.19 | 2022 | |
| Forte Bio-Pharma LLC | $70.07 | 2023 | Prolate, Nalocet |
| Horizon Therapeutics Plc | $62.49 | 2022 | |
| Redhill Biopharma INC. | $48.17 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $46.87 | 2022 | |
| Arbor Pharmaceuticals, INC. | $35.37 | 2022 | |
| Almatica Pharma LLC | $34.89 | 2022 | |
| Kyowa Kirin, INC. | $29.18 | 2025 | |
| Relievant Medsystems, INC. | $27.94 | 2023 | Intracept |
| Nevro Corp. | $25.00 | 2023 | Senza |
| Amgen INC. | $23.81 | 2022 | |
| Mml US, INC. | $23.68 | 2023 | Reactiv8 |
| Si-Bone, INC. | $21.37 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gamida Cell INC. | $17.13 | 2025 | Omisirge |
| Pfizer INC. | $16.12 | 2023 | |
| Azurity Pharmaceuticals, INC. | $15.33 | 2022 | |
| Merck Sharp & Dohme LLC | $12.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marissa Romano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.